CYDX Stock Chart & Stats
$2.70
$0.00(0.00%)
At close: 4:00 PM EDT
$2.70
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.20 - $2.90
Previous CloseN/A
Volume1.00
Average Volume (3M)116.00
Market Cap
$13.88M
Enterprise Value$2.81M
Total Cash (Recent Filing)$8.98K
Total Debt (Recent Filing)$709.29K
Price to Earnings (P/E)―
Beta-1.44
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding5,141,239
10 Day Avg. Volume80
30 Day Avg. Volume116
Financial Highlights & Ratios
PEG Ratio1.83
Price to Book (P/B)-0.47
Price to Sales (P/S)18.69
P/FCF Ratio-18.36
Enterprise Value/Market Cap0.20
Enterprise Value/Revenue42.81
Enterprise Value/Gross Profit70.58
Enterprise Value/Ebitda-9.45
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CYDX FAQ
What was CYduct Diagnostics’s price range in the past 12 months?
CYduct Diagnostics lowest stock price was $0.20 and its highest was $2.90 in the past 12 months.
What is CYduct Diagnostics’s market cap?
CYduct Diagnostics’s market cap is $13.88M.
When is CYduct Diagnostics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were CYduct Diagnostics’s earnings last quarter?
Currently, no data Available
Is CYduct Diagnostics overvalued?
According to Wall Street analysts CYduct Diagnostics’s price is currently Overvalued.
Does CYduct Diagnostics pay dividends?
CYduct Diagnostics does not currently pay dividends.
What is CYduct Diagnostics’s EPS estimate?
CYduct Diagnostics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CYduct Diagnostics have?
CYduct Diagnostics has 5,141,239 shares outstanding.
What happened to CYduct Diagnostics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of CYduct Diagnostics?
Currently, no hedge funds are holding shares in CYDX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
CYduct Diagnostics
CYduct Diagnostics, Inc. operates as a medical instrument enterprise that engineers and commercializes a diverse range of technologies, equipment, and methodologies. These innovations are purposed for the detection, diagnosis, therapeutic intervention, and general management of various health conditions and illnesses. The company's extensive product offerings include specialized breast endoscopy systems, an assortment of camera solutions (such as 3-chip and 1-chip models), and all necessary accessories. They also provide a broad selection of endoscopic instruments, encompassing surgical tools like dissectors, graspers, scissors, needle holders, fan retractors, cautery devices, and insufflation needles. Furthermore, CYduct supplies illumination series products, including fiber optic cables, light port adapters, light sources, and replacement lamps, alongside insufflators. For surgical specialties, their portfolio features laparoscopic instruments designed for general surgery, lymphadenectomy, gynecology, and thorascopy. Complementing these are rigid scopes (like laparoscopes, operative scopes, and cystoscopes) with their corresponding accessories, as well as trocar and cannula sets, video carts, and both insulated and non-insulated instrument handles. Uniquely, the company also provides instrumentation tailored for veterinary applications. Established in 1986, CYduct Diagnostics, Inc. is headquartered in Westport, Connecticut. The firm was formerly known as Solos Endoscopy, Inc., before adopting its current name in December 2020.
Technical Analysis
Aethlon Medical
―
―
Catheter Precision
―
Bluejay Diagnostics
―
Heart Test Laboratories, Inc.
―